Federal contract award
75N92024F00005
[23-009813] (NHLBI), UNDER CONTRACT NO. 75N98020D00049 REQUIRES THE FILING OF A PCT APPLICATION CLAIMING PRIORITY FROM US PRV APP. NO. 62/980,854 IN ORDER TO PURSUE INTERNATIONAL RIGHTS IN "NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHLBI |
| NAICS | 541110 — Offices of Lawyers |
| PSC | R418 — Legal Services |
| Parent award / vehicle | 75N98020D00049 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $12.0K |
| Current contract value | $12.0K |
| Potential contract value / ceiling | $12.0K |
| Start date | Aug 16, 2024 |
| Current end date | Aug 15, 2025 |
| Potential end date | Jan 6, 2026 |
| Latest award activity | Jan 9, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 9, 2025 | P00002 | $3.2K | [23-009813] (NHLBI), UNDER CONTRACT NO. 75N98020D00049 REQUIRES THE FILING OF A PCT APPLICATION CLAIMING PRIORITY FROM US PRV APP. NO. 62/980,854 IN ORDER TO PURSUE INTERNATIONAL RIGHTS IN "NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC |
| Dec 20, 2024 | P00001 | $-3.2K | [23-009813] (NHLBI), UNDER CONTRACT NO. 75N98020D00049 REQUIRES THE FILING OF A PCT APPLICATION CLAIMING PRIORITY FROM US PRV APP. NO. 62/980,854 IN ORDER TO PURSUE INTERNATIONAL RIGHTS IN "NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC |
| Aug 20, 2024 | 0 | $12.0K | [23-009813] (NHLBI), UNDER CONTRACT NO. 75N98020D00049 REQUIRES THE FILING OF A PCT APPLICATION CLAIMING PRIORITY FROM US PRV APP. NO. 62/980,854 IN ORDER TO PURSUE INTERNATIONAL RIGHTS IN "NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.